Correlation Between Medical Developments and Actinogen Medical

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Medical Developments and Actinogen Medical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Medical Developments and Actinogen Medical into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Medical Developments International and Actinogen Medical, you can compare the effects of market volatilities on Medical Developments and Actinogen Medical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Medical Developments with a short position of Actinogen Medical. Check out your portfolio center. Please also check ongoing floating volatility patterns of Medical Developments and Actinogen Medical.

Diversification Opportunities for Medical Developments and Actinogen Medical

-0.1
  Correlation Coefficient

Good diversification

The 3 months correlation between Medical and Actinogen is -0.1. Overlapping area represents the amount of risk that can be diversified away by holding Medical Developments Internati and Actinogen Medical in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Actinogen Medical and Medical Developments is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Medical Developments International are associated (or correlated) with Actinogen Medical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Actinogen Medical has no effect on the direction of Medical Developments i.e., Medical Developments and Actinogen Medical go up and down completely randomly.

Pair Corralation between Medical Developments and Actinogen Medical

Assuming the 90 days trading horizon Medical Developments International is expected to under-perform the Actinogen Medical. But the stock apears to be less risky and, when comparing its historical volatility, Medical Developments International is 2.52 times less risky than Actinogen Medical. The stock trades about -0.19 of its potential returns per unit of risk. The Actinogen Medical is currently generating about -0.01 of returns per unit of risk over similar time horizon. If you would invest  2.60  in Actinogen Medical on August 29, 2024 and sell it today you would lose (0.10) from holding Actinogen Medical or give up 3.85% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy95.65%
ValuesDaily Returns

Medical Developments Internati  vs.  Actinogen Medical

 Performance 
       Timeline  
Medical Developments 

Risk-Adjusted Performance

1 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Medical Developments International are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively stable basic indicators, Medical Developments is not utilizing all of its potentials. The current stock price uproar, may contribute to short-horizon losses for the private investors.
Actinogen Medical 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Actinogen Medical has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in December 2024. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Medical Developments and Actinogen Medical Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Medical Developments and Actinogen Medical

The main advantage of trading using opposite Medical Developments and Actinogen Medical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Medical Developments position performs unexpectedly, Actinogen Medical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Actinogen Medical will offset losses from the drop in Actinogen Medical's long position.
The idea behind Medical Developments International and Actinogen Medical pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.

Other Complementary Tools

Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Commodity Directory
Find actively traded commodities issued by global exchanges
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon